Psilocybin in Co-occuring Major Depressive Disorder and Borderline Personality Disorder

Sponsor: University of Chicago
Collaborator: Usona Institute
Recruitment Status: Not yet recruiting
First Posted: Jun 1, 2022

~

Psilocybin Therapy in Advanced Cancer

Sponsor: NYU Langone Health
Collaborator: National Cancer Institute (NCI)
Recruitment Status: Not yet recruiting
First Posted: Jun 1, 2022

~

(PREPRINT) 5-HT2CR Is as Important as 5-HT2AR in Inducing Hallucinogenic Effects in Serotonergic Compounds (Custodio et al.)

Available Online: Jun 27, 2022
SSRN

~

(Provisionally Accepted) Decreases in state and trait anxiety post-psilocybin: A naturalistic, observational study among retreat attendees (Kiraga et al.)

Available Online: Jun 1, 2022
Frontiers in Psychiatry